Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells
Accumulating evidence shows that colorectal cancer stem cells (CRSCs) are largely responsible for the metastasis and relapse of colorectal cancer (CRC) after therapy. Hence, identifying new agents that specifically target CRSCs would help improve the effectiveness of current CRC therapies. To accele...
Main Authors: | Ju, S-Y, Huang, C-YF, Huang, W-C, Su, Y |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650716/ |
Similar Items
-
Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
by: Newick, Kheng, et al.
Published: (2012) -
Thiazole Antibiotics Siomycin a and Thiostrepton Inhibit the Transcriptional Activity of FOXM1
by: Gartel, Andrei L.
Published: (2013) -
Complete Genome Sequence of Thiostrepton-Producing Streptomyces laurentii ATCC 31255
by: Doi, Katsumi, et al.
Published: (2016) -
Thiostrepton interacts covalently with Rpt subunits of the 19S proteasome and proteasome substrates
by: Sandu, Cristinel, et al.
Published: (2015) -
Draft Genome Sequence of Thiostrepton-Producing Streptomyces azureus ATCC 14921
by: Sakihara, Kengo, et al.
Published: (2015)